Graham J. Smith

Novel optimised quinuclidine squalene synthase inhibitors

G. R. Brown, A. Foubister, F. McTaggart, 1997 .

Pharmacological properties of ZD4522 — A new HMG-CoA reductase inhibitor

R. Davidson, N. Torr, W. Ward, 2000 .

Discovery of a potent, selective, and orally efficacious pyrimidinooxazinyl bicyclooctaneacetic acid diacylglycerol acyltransferase-1 inhibitor.

A. Turnbull, P. Kemmitt, A. Birch, 2009, Journal of medicinal chemistry.

Synthesis of sibutramine, a novel cyclobutylalkylamine useful in the treatment of obesity, and its major human metabolites

G. Tometzki, F. Kerrigan, Graham J. Smith, 1996 .

Inhibitors of 3-hydroxy-3-methylglutaryl-CoA reductase reduce receptor-mediated endocytosis in opossum kidney cells.

J. Sidaway, T. Orton, N. Brunskill, 2004, Journal of the American Society of Nephrology : JASN.

Preclinical and clinical pharmacology of Rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.

R. Davidson, G. Holdgate, A. McCormick, 2001, The American journal of cardiology.

Synthesis of Sibutramine, a Novel Cyclobutylalkylamine Useful in the Treatment of Obesity, and Its Major Human Metabolites.

G. Tometzki, Graham J. Smith, J. Jeffery, 1997 .